PROSYSTEM® TREC

An aid in prevention of TGE, rotaviral diarrhea, colibacillosis and enterotoxemia in nursing pigs of vaccinated sows/gilts. Unique eight-way scours protection. Freeze-dried MLV vaccine with bacterin/ toxoid diluent.

PRODUCT LABEL

PORCINE ROTAVIRUS – TRANSMISSIBLE GASTROENTERITIS VACCINE

Clostridium Perfringens Type C – Escherichia Coli bacterin-Toxoid

Modified-Live Virus

For the vaccination of healthy pregnant swine, to provide passive protection to their nursing pigs against disease caused by eight pathogens: Rotavirus (2 modified-live G serotypes 5 and 4 of serogroup A rotavirus), TGE (transmissible gastroenteritis), Colibacillosis (Escherichia coli pilus antigens K88, K99, F41 and 987P) and Enterotoxemia (Clostridium perfringens type C).

Downloads

Advantages

Safe and effective against neonatal rotaviral diarrhea, TGE, enterotoxemia and colibacillosis.

  • Aids in the prevention of enterotoxemia to reduce death loss and scours1
  • 70–100% protection against C. perfringens type C challenged litters1
  • Four major E. coli pilus types; K88, K99, 987P and F41; for comprehensive protection against colibacillosis1
  • Unique modified-live TGEV strain; acid-resistance selected for best gut-level protection1
  • First USDA-licensed vaccine with two serotypes of serogroup A rotavirus, G5 (A1) and G4 (A2), for best protection1
  • Up to 100% protection from mortality in rotavirus challenge of vaccinated sow litters1

For additional information, please see the product label.

References:

  1. Data on file, Merck Animal Health.